NASDAQ:EYE - Nasdaq - US63845R1077 - Common Stock - Currency: USD
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: CHD
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts
Small-cap stocks are sensitive to interest rates and tariffs, but AAP, LZB, and EYE offer a mix of analyst sentiment, valuation and tariff protection
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Continued strength in Managed Care aids National Vision's first-quarter 2025 performance.
Here is how Coca-Cola European (CCEP) and National Vision (EYE) have performed compared to their sector so far this year.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, National Vision (EYE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
EYE's strength in its largest brand and actions to achieve a healthier store fleet position the stock favorably.